Amine Metani

Amine Metani

Amine Metani is the Chief Scientific Officer (CSO) and co-founder of Kurage, a company that has developed Neuroskin, an AI-powered neuromuscular electrostimulation device transforming the field of rehabilitation for acquired neuromotor disabilities. He brings a rich interdisciplinary background spanning Biomedical Engineering, Computer Science, Applied Mathematics, and holds a PhD in Biophysics.

Before founding Kurage, Amine was involved in various research projects, including the development of air decontamination systems and the study of airborne fungal spore dynamics—efforts aimed at reducing the risk of hospital-acquired infections among immunocompromised patients in intensive care units.

In 2015, his focus shifted toward neurological rehabilitation following a bike accident that left his former mentor, Dr. Vance Bergeron, tetraplegic. This event marked a turning point in Amine’s career. Together, they pioneered innovative neurorehabilitation devices and therapies through an interdisciplinary approach and international collaborations. Their work has led to several patents and the founding of Kurage.

Amine’s career reflects a deep commitment to societal impact, bridging academic research and entrepreneurship to improve the quality of life for individuals living with neurological impairments through cutting-edge technologies and solutions.

Share this speaker
Share This Speaker
  • Organization
    Kurage
  • Profession
    Co-founder & Chief Scientific Officer (CSO)
Related sessions
In person
9 July 2025
15:25 - 15:45
EST - New York
CST - Beijing
PST - Los Angeles
AWST - Perth, Australia
Life can change in an instant, sometimes dramatically. A stroke,...
In person & onlineAI and industryAI and Health 
30 May 2024
10:50 - 11:30
EST - New York
CST - Beijing
PST - Los Angeles
AWST - Perth, Australia

Are you sure you want to remove this speaker?